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Creatine phosphate serves as a  reuseable high energy phosphate reservoir in 
skeletal and cardiac muscle and in the brain. These stores of creatine phosphate 
are thought to rephosphorylate the ATP hydrolyzed during cellular work (see  1 
and 2 for review). 
Studies in our laboratory (3)  have shown that mononuclear phagocytes ob- 
tained from the peritoneal cavities of mice also contain large stores of creatine 
phosphate. In resident macrophages there are 3 mol of creatine phosphate per 
mol of ATP. During phagocytosis, these creatine phosphate stores are consumed; 
presumably they are  used  to  rephosphorylate ADP,  thereby maintaining the 
energy charge and a constant ATP supply. 
The reversible transfer of the phosphoryl group of creatine phosphate to ADP 
is catalyzed by creatine kinase (CK), ~  an enzyme that exists in at least five isozymic 
forms. All forms of CK are dimers, containing subunits of ~41,000 daltons. In 
1965, Dawson et al. (4) showed that these subunits can be separated into the M 
and B forms. The BB form is found in brain, the MM form is found in skeletal 
muscle, and the heterodimer MB form is found in cardiac muscle. In addition to 
these isozymes, Jacobs et ai. (5) demonstrated that mitochondria obtained from 
rat heart and skeletal muscle express a  form of CK (mitochondrial CK) whose 
electrophoretic migration differs from that of  the three known cytoplasmic forms. 
Subsequent reports (6,  7) have established that mitochondria have at least two 
unique forms of CK. 
In this paper, we demonstrate that the expression of CK in mouse and human 
mononuclear phagocytes is a developmentally  regulated process occurring during 
the  in  vivo and in  vitro  differentiation of monocytes into macrophages. The 
induction of CK during in vitro cultivation occurs independently of the concen- 
tration of creatine in the medium. However, the size of the creatine phosphate 
pool varies directly with the concentration of creatine in the medium. 
The isozyme profile of CK in human macrophages differs from that observed 
in mouse macrophages. Human macrophages express the brain and probably the 
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mitochondrial forms of CK whereas mouse macrophages predominantly express 
the brain isozyme. These results demonstrate that in both mouse and man, CK 
is an enzymatic marker for the differentiation of monocytes into macrophages. 
Materials and Methods 
Human  Blood Monocytes.  Human blood leukocytes were isolated from venous blood 
obtained from normal healthy adult volunteers. The mononuclear leukocyte fraction was 
separated from heparinized whole blood by Ficoll-Hypaque centrifugation (8). Monocytes 
were separated from other mononuclear cells by one of two methods. In the first method, 
adhesion  of monocytes to  plastic  petri  dishes  was  used  to  separate  monocytes from 
nonadherent cells such as lymphocytes (8).  10 million mononuclear leukocytes (20-30% 
monocytes, as determined by Wright-Giemsa staining) were plated in 4 ml of RPMI 1640 
supplemented with 20% heterologous human serum and streptomycin (0.5 mg/ml) in 60- 
mm petri dishes. The nonadherent cells,  including most of the platelets, were removed 
by washing the plates several times with RPMI  1640 at 2 and 24 h. Plates washed after 2 
h contained ~3 x  106 adherent cells, over 90% of which were monocytes. As noted by 
others (8), ~40% of these adherent ceils subsequently detach from the substrate and are 
lost when the plates are washed after 24 h. The remaining cells (~1-2 ×  l0  s cells) form 
a confluent macrophage monolayer after 7-12 d  in culture. In the second method, we 
used PercoU gradient centrifugation (9) to separate monocytes from other leukocytes. 3 
million cells from the monocyte-enriched fraction of the Percoll gradient were plated into 
each 60-ram petri dish to obtain an adherent cell population that was >95% monocytes. 
In all cases, monocyte purity was determined after 7 or 14 d in culture by their morphology 
using phase contrast microscopy and by their capacity to ingest sheep erythrocytes coated 
with rabbit IgG antibody (3). 
Monocytes prepared by either method were maintained in a humidified CO2 incubator 
at 37°C. Percoll-purified monocytes were maintained either in sterile Teflon beakers as 
suspension cultures or in petri dishes as monolayer cultures for several weeks with no 
subsequent change of growth medium (10). 
Other Human  Cell Types.  Three established B lymphocyte cell lines,  8866p, Spoller, 
and DEL, prepared from mononuclear leukocytes by infection with Epstein-Barr virus, 
were a kind gift from Dr. Lloyd Mayer and Dr. Henry Kunkel. Erythrocytes were obtained 
from the pellet of the Ficoll-Hypaque gradient. T  lymphocytes were purified from the 
mononuclear cell fraction of the Ficoll-Hypaque gradients using nylon wool columns (11). 
Human neutrophils were prepared as described (12).  Platelets were isolated from whole 
blood by centrifugation of the blood at 300 g. The plasma fraction (which contains the 
platelets) was plated on 60-mm petri dishes in RPMI 1640 supplemented with 20% human 
serum. 
Murine Monocytes and Peritoneal Macrophages.  Mouse peripheral blood monocytes were 
separated  from  heparinized  mouse  blood and  other  leukocytes using  Ficoll-Hypaque 
centrifugation (13). The Ficoll-Hypaque gradient was prepared by layering 1 part Ficoll- 
Hypaque of 1.077 density onto 4 parts of Ficoll-Hypaque of density 1.119.  Blood was 
collected from the  mouse heart using a  heparinized (100  USP units per  1 ml  blood) 
syringe and the blood was immediately diluted  1:4 with Dulbecco's phosphate-buffered 
saline containing Ca ++ and Mg  ++ (PBS) (14).  35 ml of the diluted blood was layered onto 
a  15-ml Ficoll-Hypaque gradient and centrifuged at 500 g in an IEC centrifuge (Interna- 
tional Equipment Co.,  Needham Heights,  MA)  for 20 min at room temperature. The 
mononuclear cell fraction located near the  1.077:1.119  interface of the gradient was 
carefully removed and the cells washed twice in PBS. The monocytes were separated from 
lymphocytes by adherence on plastic petri dishes.  Mononuclear cells were plated at an 
initial density of 10 million per 60-mm petri dish and maintained in culture in  RPMI 
1640 medium supplemented with 20% fetal bovine serum and 0.5 mg/ml streptomycin. 
The cultures were washed with RPMI  1640 after 6 h; ~15-25% of the cells remained 
adherent. Mouse peritoneal macrophages were obtained from NCS mice (The Rockefeller 
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lected as described (3) and plated in 35-mm petri dishes at densities of 6 and 2 x  106 cells 
per dish, respectively. After a  24-h incubation there were ~1.5-1.8  x  106 macrophages 
per p&ri dish.  The mouse macrophages were maintained  in minimal essential  medium 
supplemented with  10% fetal bovine serum and 0.5 mg/ml streptomycin. 
ATP and Creatine Phosphate Measurements.  Macrophages or monocytes maintained  in 
35 or 60-mm petri dishes were washed three times in PBS, scraped with a rubber policeman 
into 0.4 ml of cold (4°C) 0.04M Tris/borate buffer, pH 9.2. A 200-~1 aliquot was removed 
for CK determination and the remaining sample was boiled for 5 min and centrifuged at 
4°C in an  Eppendorf microcentrifuge for 5  min at  11,700 rpm.  The supernatant  was 
immediately transferred to a test tube and frozen, by submerging the test tube in a -40 °C 
dry ice-acetone bath.  Samples were maintained  frozen for no longer than  2  wk before 
measuring ATP and  creatine  phosphate.  ATP and  creatine  phosphate  were  measured 
using a  luciferin-luciferase system.  ATP was measured in duplicate samples at 4°C in a 
Packard  liquid  scintillation  counter  (Packard  Instrument  Co.,  Downers  Grove,  IL) as 
described  (3,  15).  Measured  amounts  of ATP  were  run  as  standards  in  every assay. 
Creatine  phosphate  measurements  were  performed  at  37°C  with  a  Packard  Pico-lite 
luminometer by a modification of previously described methods (3).  Briefly, aliquots (30 
#1) of extracts were added to 350 #1 of assay buffer containing  123 vl of 0.01  M  KPO~ 
buffer, pH 7.4 (containing 4 mM MgSO,),  123 ~1 of 0.1  Na arsenate buffer (pH 7.4), 36 
#1 of 10 mM AMP, 36 #1 of reconstituted firefly extract,  23 #1 H20, and 9 #1 of 0.1  mM 
ADP. The firefly extracts were incubated at 37°C for 10 min before use to hydrolyze any 
endogenous ATP.  Samples were incubated  in the  Pico-lite  luminometer at  37°C for 5 
min before recording baseline ATP levels (measured by light intensity).  Then,  50 #1 of 
CK  (5  mg/ml)  was  added  and  the  emitted  light  was  recorded.  The  additional  light 
generated after the addition of CK represents ATP generated from CK-catalyzed transfer 
of phosphoryi groups from creatine  phosphate  to ADP (creatine  phosphate  +  ADP 
creatine  +  ATP).  The  maximum  amount  of ATP  generated  under  these  conditions 
occurred within 40-60 s. The difference between the maximum and initial light intensity 
(before and after the addition of CK) was directly proportional to the concentration of 
creatine  phosphate  standard added to the  incubation mixture  over a  range of 10  -*1 to 
10 -9 mol of creatine phosphate (Fig.  1). Samples and creatine phosphate standards were 
measured in duplicate for each experiment. 
CK Activity and lsozyme Identification.  Tris/borate extracts of cell cultures, prepared as 
described above, were sonicated at 4°C for 10 s using an Ultrasonic cell disrupter (Heat 
Systems-Ultrasonic, Inc., Plainview, NY) set at 25% duty cycle and 2.5 output units, and 
centrifuged in a Sorvall centrifuge (DuPont Instruments, Wilmington, DE) at 10,000 g at 
4 °C for 60 min. The supernatants were used immediately to measure CK activity and to 
determine the CK isozymes. No difference was observed in CK activity whether the cells 
were lysed by Tris-borate sonification or in Triton X-100 (unpublished data). CK activity 
was measured as described  (16) by monitoring the  forward reaction  of creatine  kinase 
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FIGURE  1.  The measurement of creatine phosphate using a bioluminescence assay. Standard 
concentrations ofcreatine phosphate (10-  - 1  O- ) were measured as a function of  light intensity 
using a Pico-lite luminometer as described  in Materials and Methods. LOIKE,  KOZLER,  AND  SILVERSTEIN  749 
(creatine phosphate to ATP) in a coupled reaction mixture containing NADP, hexokinase, 
and glucose 6-phosphate dehydrogenase. The rate of this reaction was followed spectro- 
photometrically  by  measuring  the  reduction  of  NADP  to  NADPH.  To  control  for 
endogenous  ATP  in  the  extracts or for enzymatic activities that  may catalyze NADP 
reduction, the rate of NADPH formation was measured in samples from which creatine 
phosphate was omitted. The values reported represent the difference between the rate of 
NADPH generated in the presence and absence of added creatine phosphate. One IU of 
CK is defined (16) as the concentration of enzyme required to convert 1 #mol of creatine 
phosphate to 1 t~mol of creatine in 1 min. 
CK  isozymes were  analyzed  by electrophoresis of Tris-borate extracts  on  cellulose 
acetate plates at 4°C using the Helena CK isozyme separation procedure (Helena Labo- 
ratories, Beaumont, TX) (17). Individual CK isozyme bands on the plates were developed 
for 30 min at 37°C in the coupled reaction (described above) and the NADPH generated 
was visualized under UV light. Tracings of the fluorescence bands were recorded using a 
Helena recording spectrofluorometer (model CCU). For all determinations of human CK 
isozyme, commerical human CK isozymes were run as standards.  For studies of mouse 
macrophages, standard mouse CK isozymes were separated using mouse skeletal muscle 
as the source for the MM isozyme, mouse heart as the source for MB isozyme, and mouse 
brain as the source for the BB isozyme (18). 
Miscellaneous Techniques.  Protein  determinations  were  made  using  the  method  of 
Lowry et al. (19) on sonicated Tris-borate extracts (20 ~tl) dissolved in 100 ~tl 1 N NaOH 
and neutralized with 100/~! of 1 N HCI. The concentration of Tris in these extracts did 
not interfere with protein determinations.  All cultures  used in  these studies contained 
>95%  viable cells as determined by trypan blue exclusion (20).  Dialyzed human serum 
was prepared by dialysis for 3 d against 100 vol of 0.9% NaCI, which was replaced daily 
with  fresh  saline.  Creatine  concentrations  in  serum  were  -1-2  ×  10 -5  M  and  were 
measured as described (21).  All experiments were repeated at least three times and, in 
most cases, duplicate samples were used for each experiment. 
Materials.  Brewer's thioglycollate broth was purchased in  powder form from Difco 
Laboratories, Detroit, MI and prepared as described on the package. RPMI 1640, Eagle's 
minimal essential medium, and fetal bovine serum were purchased from Gibco Labora- 
tories, Grand Island, NY. ATP, firefly lanterns, creatine phosphate, creatine, hexokinase, 
and glucose 6-phosphate dehydrogenase were purchased from Sigma Chemical Co.,  St. 
Louis, MO.  CK was purchased from Boehringer Mannheim Biochemicals, Indianapolis 
IN. Heparin (Lipo-Hepin, 5,000 USP units per ml) was purchased from Riker Laborato- 
ries,  Northridge,  CA.  Percoll and  Ficoil-Hypaque were obtained from Pharmacia Fine 
Chemicals, Piscataway, NJ. All  materials used for the electrophoretic separation of CK 
isozymes were  purchased  from  Helena  Laboratories.  Human  and  rabbit  CK  isozyme 
standards were obtained from Roche Diagnostics, Nutley, NJ and Helena Laboratories, 
respectively. Rabbit antiserum directed against human CK-BB was purchased from Or- 
ganon Diagnostics, West Orange,  NJ and rabbit anti-human MM antiserum was a kind 
gift  of Dr.  Robert  Roberts,  Washington  University,  St.  Louis,  MO.  Goat antiserum 
directed  against  human  CK-MM  was purchased  from  Merck  AG,  Darmstadt,  Federal 
Republic of Germany. Human serum for culturing human monocytes was obtained from 
healthy volunteers with type A blood. 
Results 
Creatine  Phosphate  and  CK  Activity  in  Mouse  Monocytes  and  Peritoneal  Macro- 
phages.  Mouse monocytes maintained in culture for 24 h  contain no detectable 
creatine phosphate or CK activity (Table I). Mouse macrophages obtained from 
the peritoneal cavities of normal mice and maintained in culture for 24 h express 
70 mU of CK per mg protein and contain about 2.2 mol of creatine phosphate 
per mol of ATP  (Table I) (3).  Mouse monocytes maintained  in culture  for 7  d 
appear morphologically like peritoneal macrophages and express significant CK 750  CREATINE  KINASE  AND  CREATINE  PHOSPHATE  IN  MACROPHAGES 
TABLE  I 
ATP, Creatine Phosphate, and CK in Mouse Monocytes and Macrophages* 
Time in  Creatine  ATP  CK  Protein  culture  phosphate 
nmol/mg  mU/mg  mg 
Mouse monocytes  24 h  10.0  <0.3*  <3.0  0.23 
7 d  ND  0  ND  120  0.4 
Mouse peritoneal macrophages 
Resident 
Thioglycollate elicited 
24 h  2.6  8.0  70  0.14 
2 h  11.9  35  370  0.19 
24 h  8.8  47  350  0.22 
7 d  2.5  550  1100  0.40 
* Prepared and measured as described in Materials and Methods. 
* Low concentrations of creatine phosphate may be due to contaminating platelets and not monocytes 
present in the cell preparation. 
0 Not determined. 
activity (120 mU/mg protein; Table I). Since peritoneal macrophages are derived 
from blood monocytes (22),  these results suggest that the expression of CK in 
mouse macrophages is a developmentally controlled process induced during both 
in vivo and in vitro differentiation of monocytes. 
Enhanced expression of CK  is  also observed during  in  vitro cultivation  of 
inflammatory macrophages.  Inflammatory macrophages, elicited by the intra- 
peritoneal injection of thioglycoilate broth and maintained in culture for 2 and 
24 h, contain 3 and 5  tool of creatine phosphate per mol of ATP and express 
350 and 370 mU of CK per mg protein, respectively (Table I). Thioglycollate- 
elicited macrophages maintained in culture for 7 d show a threefold increase in 
the specific activity of CK  (1,100  mU/mg) and an  ~20%  increase in creatine 
phosphate (Table  I) when compared with the same cells cultured for 24  h  or 
less. 
To examine the induction of CK during monocyte differentiation in greater 
detail, we measured CK expression in human monocytes and in monocyte-derived 
macrophages. Human monocytes were chosen for this study because these cells 
can be obtained in large numbers from venous blood and are known to differ- 
entiate in culture (8, 22, 23). 
CK and Creatine Phosphate in Cultured Human Monocytes and in Monocyte-derived 
Macrophages.  Human monocytes maintained in culture for 24 or 48 h contain 
<3  mU of CK per mg protein (the lower limit of detection in  this assay) and 
undetectable levels of creatine phosphate.  The ATP content of these cells was 
~4 nmol per mg protein. An increase in monocyte CK activity was first detected 
on the 5th d  of culture. By 7 and  14 d, these adherent cell cultures contained 
20  and  100  mU of CK per mg protein,  respectively (Fig.  2).  Creatine kinase 
activity did not usually increase after 21 d in culture. Thus, in human monocyte- 
derived macrophages, CK is developmentally regulated; that is, its expression is 
dependent on the length of in vitro cultivation. 
To examine whether cell adherence is required for CK expression, monocytes 
purified by Percoll centrifugation were maintained either as adherent cells in LOIKE,  KOZLER,  AND  SILVERSTEIN 
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FIGURE 2.  CK activity of human monocytes maintained in culture. Human monocytes were 
isolated by Ficoll-Hypaque centrifugation and selective adherence to plastic substrate  or by 
Percoll gradient centrifugation as described in Materials and Methods. Percoll-purified mon- 
ocytes were maintained either as suspension cultures in Teflon beakers or as adherent cultures 
in petri dishes.  At the indicated times, cultures were harvested, extracts prepared,  and CK 
activity measured  as described  in  Materials  and  Methods.  The  results  presented  are of a 
representative experiment. The experiment was repeated three times with similar results. (A) 
Percoll-purified monocyte cultures maintained as suspension cultures in Teflon, ((3) Percoll- 
purified cells maintained  as adherent  cultures,  (0)  monocytes prepared  by Ficoll-Hypaque 
centrifugation and selective adherence. 
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Petri dishes or as suspension cultures in Teflon beakers. The rate and extent of 
CK induction was the same in these cells as in monocytes maintained in monolayer 
cultures (Fig. 2). These experiments show that the expression of CK is independ- 
ent of cell adherence to the plastic substrate. 
Dialyzed human  serum  contains  <10 -6  M  creatine.  Human  macrophages, 
maintained for 14 d in medium supplemented with 20% dialyzed human serum, 
contained normal amounts of CK (95  mU/mg protein), but no creatine phos- 
phate.  Addition  of  10 -4  M  guanidinoacetic acid  (the  metabolic precursor  to 
creatine) to the medium did not promote creatine phosphate accumulation, even 
though the cells contained the expected concentration of CK  (100  mU/mg). 
These experiments demonstrate that monocyte-derived macrophages, like brain 
and muscle cells (1), do not contain the appropriate enzymes to synthesize creatine 
from its known precursors (glycine and guanidinoacetic acid) and must therefore 
obtain creatine from serum. 
The specific activity of CK in macrophages maintained in medium containing 
high concentrations of creatine (10  -~ M) was identical to that found in macro- 
phages maintained in  medium containing low concentrations (2  x  10 -6 M) of 
creatine (data not shown). Thus, CK induction is independent of the presence 
or amount of creatine present in the medium or of creatine phosphate in the 
cells. 
Another feature associated with differentiation of monocytes into macrophages 
in culture is the development of a creatine phosphate reservoir (Fig. 3).  Mono- 
cytes maintained in medium supplemented with  1.0 mM creatine contain two- 
to  threefold the  amount  of creatine  phosphate  and  approximately the  same 
amount of ATP as monocytes maintained in  medium containing 2  X  10 -6 M 
creatine (Fig. 3). Thus, the size of the creatine phosphate pool, unlike the specific 
activity of CK, depends on the creatine concentration in the medium. 752  CREATINE  KINASE  AND  CREATINE  PHOSPHATE  IN  MACROPHAGES 
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FIGURE 3.  ATP and creatine phosphate levels in monocyte cultures. Human monocytes were 
isolated by Ficoll-Hypaque gradient centrifugation and selective adherence as described in 
Materials  and  Methods  and  were  maintained as  adherent  cultures  in  the  absence (O)  or 
presence (O) of an additional 1.0 mM creatine. ATP and creatine phosphate were measured 
at the indicated times. Each point represents the average of duplicate samples. The standard 
deviation from the average of the duplicate samples was <15%. 
Isozyme Pattern  of CK in Human  and Murine Macrophages.  Electrophoresis of 
CK from human monocytes maintained in culture for 7  or  14  d  reveals three 
bands that possess CK activity (Fig.  4a).  The anodal band corresponds to the 
brain type of CK (BB), based on its electrophoretic mobility and the capacity of 
antiserum to the BB isozyme to inhibit its activity (Fig. 4a). Control experiments 
(Fig. 4 b) demonstrate that the anti-BB antiserum inhibits the BB and MB isozymes 
but not the MM isozyme. 
The isozyme that migrates further towards the cathode than the MM standard 
is not inhibited by either anti-BB or anti-MM antisera; based on its mobility, it 
appears to be a mitochondrial form of CK (4-6). 
The identity of the isozyme that has an electrophoretic mobility corresponding 
to the MM isozyme is less clear. Goat and rabbit anti-human MM antisera do not 
abolish its activity (Fig.  4), while both antisera inhibit the activity of standard 
human MM isozyme. Furthermore, the intensity of this band relative to the BB 
band varies with macrophages from different donors. 
The isozyme pattern  of human macrophages differs from that  observed in 
tissue  macrophages  obtained  from  mice.  Resident  and  thioglycollate-elicited 
macrophages from mice contain one major band, the BB isozyme of CK (Fig. 5). 
There are also traces of enzyme activity whose electrophoretic mobility is similar 
to the MM isozyme. 
Creatine Phosphate  and CK in Other Blood Cells.  We have found that human 
platelets, freshly isolated from whole blood (Fig.  5 and Table II), contain both 
CK and creatine phosphate. In contrast, freshly isolated human blood T  and B 
lymphocytes (from which the monocytes have been removed by a  Percoll cen- 
trifugation step), erythrocytes  and polymorphonuclear leukocytes contain neither 
CK nor creatine phosphate.  B  lymphocytes transformed by Epstein-Barr virus LOIKE,  KOZLER,  AND  SILVERSTEIN  753 
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FIGURE 4.  (a)  Electrophoretic  analysis  of  CK  isozymes  in  human  macrophages.  Human 
macrophage extracts  were  prepared  from  14-d-old cultures as  described  in  Materials and 
Methods. Extracts were preincubated for 30 min at 37 °C with a  1:100 dilution of nonimmune 
sheep serum (top),  sheep anti-MM antiserum (middle),  or anti-BB antiserum (bottom).  Electro- 
phoresis was done as described in Materials and Methods. The MM,  MB, and BB indicator 
marks are the relative positions where standard MM,  MB, and BB isozymes migrate on the 
cellulose acetate plates. (b) Electrophoretic patterns of human CK standards incubated in the 
presence or absence of antisera directed against either the MM or BB isozyme. Human CK 
standards were preincubated for  30 min at 37°C  in a  1:100 dilution of nonimmune sheep 
serum (top), sheep anti-MM antisera (middle), or sheep anti-BB antisera (bottom).  The antisera- 
CK mixtures were then loaded on cellulose acetate plates and electrophoresed as described in 
Materials and Methods. 
and maintained as continuous cell lines do not express CK and have no detectable 
creatine phosphate. 
Discussion 
In  vitro  cultivation of monocytes results  in  morphological and  biochemical 
changes that mimic, in part, differentiation in vivo. Changes that occur during 
in vitro cultivation of human monocytes include increases in cell size (8), the loss 
of myeloperoxidase staining (23), decreased capacity to release reactive oxygen 
intermediates (23),  increased capacity to ingest antibody-coated particles (10), 
and qualitative changes in the activities of the C3b and C3bi receptors (10). 
This paper identifies CK as a new marker for the differentiation of monocytes 
into macrophages. Our results demonstrate that the expression of CK and the 
accumulation of a  creatine phosphate reservoir is a  developmentally regulated 
process  in  cultured  human  and  mouse  monocytes.  Our  finding  that  mouse 
monocytes lack CK and creatine phosphate while tissue  macrophages contain 
both CK and creatine phosphate provides direct evidence that the expression of 754  CREATINE  KINASE  AND  CREATINE  PHOSPHATE  IN  MACROPHAGES 
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FIGURE 5.  CK  isozymes  in  mouse  thioglycollate-elicited macrophages  (thio-macrophages) 
and  human  platelets.  Tris/borate  extracts  were  prepared  (as  described  in  Materials  and 
Methods)  from  mouse  resident  macrophages  (top) and  thioglycollate-elicited macrophages 
(middle) maintained  in  culture  for  1  d,  and  freshly  isolated  human  platelets (bottom). CK 
isozymes were separated by electrophoresis on cellulose acetate plates as described in Materials 
and Methods. 
TABLE  II 
ATP, Creatine Phosphate, and CK in Platelets, Erythrocytes, Lymphocytes, and 
Polymorphonuclear Leukocytes* 
Time in  Creatine  ATP  CK  culture  phosphate 
nmol/mg  mU/mg 
Human platelets (4.7 ×  106 cells)  3 h  2.1  0.8  ND 
Lymphocytes (B and T  cells) (5 ×  106)  3 h  30  <1.0'  <2.0 
Polymorphonuclear leukocytes (3 x  106 cells)  3 h  17.2  0.9  <5.0 
Erythrocytes (1.8 ×  108 cells)  3 h  25.9  <0.01  <3.0 
B lymphocytes (8866p) (4 x  106)  7 d  8.0  <0.01  <2.0 
* Prepared and measured as described in Materials and Methods. 
* Low concentrations of creatine phosphate may be due to contaminating platelets and not monocytes 
present in the cell preparation. 
CK  by  macrophages  is  not  an  artifact  of in  vitro  cultivation.  Furthermore, 
preliminary  studies  indicate  that  CK  is  also  expressed  in  macrophages  from 
human tissue. Alveolar macrophages obtained by bronchial lavage from a single 
patient contained significant CK activity (70 mU/mg protein). 
Neither mouse peritoneal macrophages nor human monocyte-derived macro- LOIKE,  KOZLER,  AND  SILVERSTEIN  755 
phages are able to synthesize creatine from its known precursors, guanidinoacetic 
acid and glycine. Therefore, maintenance of a  creatine phosphate pool  is de- 
pendent upon a continuous supply of creatine in the medium. This is also evident 
from our observation that murine peritoneal macrophages decrease their creatine 
phosphate stores by 90% when maintained in culture for several days in medium 
lacking creatine (Loike and Silverstein, manuscript in preparation). 
Five isozymes of CK have been described (4, 6). We demonstrate that human 
monocyte-derived macrophages express at least two and possibly three of these 
isozymes. We have identified one of these isozymes as the brain form of CK. 
Further work is required to establish the identity of the second isozyme, which 
we believe is the mitochondrial form of CK.  The identity of the CK isozyme 
whose electrophoretic mobility is similar to the MM isozyme remains unclear, 
since activity of this isozyme is not inhibited by the two anti-MM antisera that 
we have tested. 
Two  important  similarities  between macrophages and  muscle cells (23-25) 
emerge from these studies.  In both  cell types, creatine cannot be synthesized 
from its known precursors and must be obtained from extracellular sources, and, 
CK expression accompanies cellular differentiation. 
What is the role of creatine phosphate in human and mouse macrophages? We 
have previously shown (3)  that during the ingestion of antibody-coated sheep 
erythrocytes by  mouse  macrophages,  creatine  phosphate  turnover  increases 
dramatically. Yet all experimental evidence indicates that ATP and not creatine 
phosphate fuels phagocytosis.  Mouse macrophages depleted of >90%  of their 
creatine phosphate stores continue to phagocytose. Studies with human phago- 
cytes  confirm  that  the  presence  of  creatine  phosphate  is  not  required  for 
phagocytosis. Human monocytes and polymorphonuclear leukocytes lack crea- 
tine phosphate and CK and are able to phagocytose a wide variety of particles. 
Thus, it appears that, in macrophages, the development of a creatine phosphate 
pool is one of perhaps many mechanisms for maintaining constant ATP levels in 
the face of sporadic demands for chemical energy during cellular work. 
Summary 
We have studied the expression of creatine kinase (CK) and the accumulation 
of creatine phosphate during the differentiation of human and mouse peripheral 
blood monocytes. Mouse monocytes cultured for 24 h do not contain detectable 
levels of CK and creatine phosphate. However, resident tissue macrophages and 
inflammatory elicited macrophages obtained from the peritoneal cavities of mice 
have 70 and 300 mU per mg protein of CK activity and contain 3 and 6 mol of 
creatine phosphate per tool of ATP, respectively. The major isozyme of CK in 
these cells has been identified as the brain form. These findings suggest that the 
differentiation of monocytes into macrophages is associated with the expression 
of CK and the accumulation of creatine phosphate.  We have found a  similar 
pattern in human monocytes. Human blood monocytes, maintained in culture 
for 24 or 48  h, do not contain detectable levels of CK or creatine phosphate. 
Monocyte-derived macrophages (monocytes maintained in tissue cultures for  1 
to 2 wk) have up to  100 mU per mg protein of CK activity and contain 0.5 mol 
of creatine phosphate per mol of ATP. Human macrophages express multiple 756  CREATINE  KINASE AND  CREATINE  PHOSPHATE  IN  MACROPHAGES 
isozymes of CK including the brain  (BB) and possibly the mitochondrial forms 
of this enzyme.  Thus,  the expression of CK and  the  accumulation  of creatine 
phosphate  in  human  monocytes is  induced  by  their  in  vitro  cultivation.  The 
induction of CK during in vitro cultivation occurs independently of the concen- 
tration of creatine in the medium.  However, the size of the creatine phosphate 
pool varies with respect to extracellular creatine concentration. Creatine phos- 
phate and CK are not detectable in freshly isolated human  lymphocytes, poly- 
morphonuclear  leukocytes  or  erythrocytes,  but  are  found  in  freshly  isolated 
human platelets. 
We wish to thank Carl Nathan, Michele Somes, and Martha Furie for critical reading of 
the manuscript. 
Received for pu btica  tion 14 November 1983. 
References 
1.  Walker, J.  B.  1979.  Creatine:  biosynthesis, regulation and function. Adv.  Enzymol. 
Relat. Areas Mol. Biol.  50:177. 
2.  Bessman, S. P., and P.J. Geiger. 1981. Transport of energy in muscle:the phosphor- 
ylcreatine shuttle. Science (Wash. DC). 211:448. 
3.  Loike, J. D.,  V. F. Kozler, and S. C. Silverstein. 1979. Increased ATP and creatine 
phosphate turnover in phagocytosing mouse peritoneal macrophages. J. Biol.  Chem. 
254:9558. 
4.  Dawson,  D.  M.,  H.  M.  Eppenberger,  and  N.  O.  Kaplan.  1965.  Creatine  kinase: 
evidence for a dimeric structure. Biochem. Biophys. Res. Commun.  21:346. 
5.  Jacobs, H., H. W. Heldt, and M. Klingenberg. 1964. High activity of creatine kinase 
in  mitochondria from muscle and  brain and  evidence for separate  mitochondrial 
isoenzyme of creatine kinase. Biochem. Biophys. Res. Commun.  16:516. 
6.  Kanemitsu, F.,I. Kawanishi, andJ. Mizushima. 1982. Characteristics of mitochondrial 
creatine kinase from normal human heart and liver tissues. Clin. Chim. Acta.  119:307. 
7.  Kanemitsu, F., I. Kawanishi, and J.  Mizushima.  1983. A new creatine kinase found 
in mitochondrial extract from malignant liver tissues.  Clin.  Chim. Acta.  128:233. 
8.  Johnson,  W.  D., Jr.,  B.  Mei,  and  Z.  A.  Cohn.  1977.  The  separation,  long-term 
cultivation, and maturation of the human monocyte.  J. Exp. Med.  146:1613. 
9.  Gmelig-Meyling, F., and T. A. Waldmann.  1980. Separation of human blood mono- 
cytes and lymphocytes on a continuous Percoll gradient. J. Immunol. Methods.  33: I. 
! 0.  Wright, S. D., and S. C. Silverstein. 1982. Tumor-promoting phorbol esters stimulate 
C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.J. Exp. 
Med.  156:1149. 
11.  Julius,  M.  H.,  E. Simpson, and L.  A.  Herzenberg.  1973.  A rapid method for the 
isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol.  3:645. 
12.  English,  D., and B.  R.  Andersen.  1974.  Single step separation of red blood cells, 
granulocytes and mononuclear teukocytes on discontinous density gradients of Ficoll- 
Hypaque.J. hnmunol. Methods 5:249. 
13.  Wirth, J. J., M. A. Theisen, and A. J. Crowle. 1982. Culture conditions required for 
primary isolation and study of mouse blood monocytes.J. Reticuloendothel.  Sac. 31:325. 
14.  Dulbecco, R., and M. Vogt. 1954. Plaque formation and isolation of pure lines with 
poliomyelitis viruses. J. Exp. Med. 99:167. 
15.  Stanley, P. E., and S. G. Williams.  1969. Use of the liquid scintillation spectrometer 
for determining ATP by the luciferase enzyme. Anal. Biochem. 29:38 I. LOIKE.  KOZLER, AND  SILVERSTEIN  757 
16.  Horder, M., E. Magid, E. Pitkanen, M. Harkonen, J. H. Stromme, L. Theodorsen, 
W. Gerhardt, and J. Waldenstrom.  1979.  Recommended method for the determi- 
nation of creatine kinase in blood. Scand. J. Clin.  Lab. Invest.  39:1. 
17.  Trainer, T. D., and D. Gruenig.  1968. A rapid method for the analysis  of creatine 
phosphokinase isoenzymes. Clin.  Chim. Acta.  21 : 151. 
18.  Lough, J., and R. Bischoff. 1977. Differentiation of creatine phosphokinase during 
myogenesis. Dev. Biol.  57:330. 
19.  Lowry, O.  H.,  N. J.  Rosebrough,  A.  L.  Farr,  and  R. J.  Randall.  1951.  Protein 
measurement with the folin phenol reagent.J. Biol.  Chem.  193:265. 
20.  Boyse, E. A., L.J. Old, and J. Chouroulinkov. 1964. Cytotoxic test for demonstration 
of mouse antibody. Methods Med. Res.  10:39. 
21.  Yasuhara, M., S. Fujita, K. Arisue, K. Kohda, and C. Hayashi. 1982. A new enzymatic 
method to determine creatine. Clin Chim. Acta  122:181. 
22.  Sutton, J.  1967.  Ultrastructural aspects of in vitro development of monocytes into 
macrophages, epitheloid cells and multinucleated giant cells. Natl. Cancer Inst. Monogr. 
6:71. 
23.  Nakagawara, A., C. F. Nathan, and Z. A. Cohn. 1981. Hydrogen peroxide metabolism 
in human monocytes during differentiation in vitro. J. Clin.  Invest. 68:1245. 
24.  Kloosterboer, H.J., S. A. Stoker-De Vries, and F. A. Hommes. 1976. Development 
of creatine kinase in rat skeletal muscle. Enzyme (Basel). 21:448. 
25.  Fitch, C. D. 1977. Significance of abnormalities ofcreatine metabolism. Excerpta Med. 
Int. Congr.  Ser.  404:328. 